glp 1 receptor agonist use and risk of suicide death Glucagon-Like Peptide-1 Agonists for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes: A Target Trial Emulation Study: Annals Internal Medicine: Vol 177, No 8 GLP-1 Meds Linked to 265

Risks, Regulatory Issues, and Safety Concerns Peptides may sound like an exciting shortcut for muscle maintenance, but they come with significant risks when they are unregulated or when used without medical supervision

Pharmacology 100 (5-6), 292300

Inflammation and oxidative stress The impact of GLP-1RAs on hepatic lipotoxicity has been extensively explored in cellular and animal models, whereas few clinical studies have been conducted ( Gut-liver axis Lipoproteins production by the liver and by the intestine is subject to a variety of hormonal and nutritional modulators and is deranged in T2D as well as in insulin resistant states including NAFLD ( GLP-1RAs and clinical trials in NAFLD Lixisenatide In a systematic meta-analysis including 12 randomized controlled trials (RCTs) comparing lixisenatide to placebo or active interventions in T2D, lixisenatide was reported to normalize levels of alanine aminotransferase (ALT) in a greater proportion of overweight and obese patients with T2D than comparators ( Exenatide Almost all human studies with exenatide twice-daily evaluating NAFLD-related endpoints involve patients with T2D

Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial